DiaMedica Therapeutics Inc.

NASDAQ (USD): DiaMedica Therapeutics Inc. (DMAC)

Last Price

6.41

Today's Change

+1.54 (31.62%)

Day's Change

4.75 - 6.41

Trading Volume

235,468

Overview

Market Cap

274 Million

Shares Outstanding

42 Million

Avg Volume

82,842

Avg Price (50 Days)

4.65

Avg Price (200 Days)

3.59

PE Ratio

-11.45

EPS

-0.56

Earnings Announcement

17-Mar-2025

Previous Close

4.87

Open

4.76

Day's Range

4.75 - 6.41

Year Range

2.14 - 6.41

Trading Volume

216,386

Price Change Highlight

1 Day Change

31.62%

5 Day Change

18.48%

1 Month Change

53.35%

3 Month Change

55.21%

6 Month Change

196.76%

Ytd Change

126.50%

1 Year Change

127.30%

3 Year Change

81.07%

5 Year Change

54.46%

10 Year Change

663.10%

Max Change

-75.32%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase 2 REDUX trial for the treatment of patients with moderate or severe chronic kidney disease caused by Type I or Type II diabetes; and Phase 2/3 REMEDY2 trials for the treatment of patients with acute ischemic stroke. It is also developing DM300 that is in pre-clinical stage for the treatment of inflammatory diseases. The company was formerly known as DiaMedica Inc. and changed its name to DiaMedica Therapeutics Inc. in December 2016. DiaMedica Therapeutics Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment